Lineage Cell Therapeutics, Inc. - COM (LCTX)

Historical Portfolio Holders from Q2 2019 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
94.4M
Holdings value Q2 2024
$94.2M
Value change Q2 2024
+$447K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
110
Number of buys Q2 2024
39
Number of sells Q2 2024
-35
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 84.7K $76.6K +$46K $0.90 2
2024 Q2 94.4M $94.2M +$447K $1.00 111
2024 Q1 93.4M $138M +$26.5M $1.48 113
2023 Q4 75.7M $82.5M +$189K $1.09 114
2023 Q3 75.5M $89.1M -$399K $1.18 103
2023 Q2 75.6M $107M +$8.46M $1.41 105
2023 Q1 69.8M $105M +$7.2M $1.50 115
2022 Q4 65.1M $76.1M +$592K $1.17 99
2022 Q3 64.7M $73.1M -$348K $1.13 89
2022 Q2 65M $103M -$12.1M $1.58 85
2022 Q1 72.8M $112M -$3.92M $1.54 100
2021 Q4 74M $181M -$5.35M $2.45 111
2021 Q3 75.8M $192M +$6.65M $2.52 106
2021 Q2 73.1M $209M +$38M $2.85 101
2021 Q1 60.3M $142M +$12.4M $2.35 88
2020 Q4 55.1M $96.9M +$3.14M $1.76 77
2020 Q3 53.6M $50.2M -$1.85M $0.94 65
2020 Q2 55.7M $48.5M -$6.97M $0.87 80
2020 Q1 63.8M $52.9M +$406K $0.83 80
2019 Q4 63.3M $56.4M -$1.15M $0.89 85
2019 Q3 64.5M $63.2M +$63M $0.98 80
2019 Q2 18K $20K +$20K $1.11 1